Next-Generation Non-Invasive Flow Monitoring System

Publication ID: 24-11857301_0005_PTD
Published: November 07, 2025
Category:Future Evolutions & Paradigm Shifts

Legal Citation

pr1or.art Inc., “Next-Generation Non-Invasive Flow Monitoring System,” Published Technical Disclosure No. 24-11857301_0005_PTD, Published November 07, 2025, available at https://archive.pr1or.art/24-11857301_0005_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,301.

Summary of the Inventive Concept

A revolutionary, wearable, and implantable flow monitoring system that enables real-time, three-dimensional imaging of fluid flow patterns within living organisms, providing unprecedented insights into cardiovascular health and disease diagnosis.

Background and Problem Solved

The original non-invasive flow monitoring patent has limitations in terms of spatial resolution, depth penetration, and real-time imaging capabilities. The new inventive concept addresses these limitations by introducing a multi-spectral illumination source, an array of light sensors, and advanced signal processing algorithms to provide high-resolution, three-dimensional imaging of fluid flow patterns.

Detailed Description of the Inventive Concept

The next-generation flow monitoring system comprises a wearable device with a flexible, conformable substrate, a light source, and a light sensor embedded in the substrate. The system utilizes a beam of coherent, multi-spectral light to illuminate the organism, and an array of light sensors detects spatially-resolved patterns of constructive and destructive interference in light emitted from the organism. The system generates a three-dimensional image of fluid flow patterns within the organism based on the detected patterns, enabling real-time monitoring of cardiovascular health. Additionally, the system includes a wireless communication module for transmitting flow property data to a remote monitoring system and is powered by a thin-film battery integrated into the substrate.

Novelty and Inventive Step

The new claims introduce the concept of multi-spectral illumination, spatially-resolved detection of interference patterns, and advanced signal processing algorithms to generate high-resolution, three-dimensional images of fluid flow patterns. These advancements provide a significant improvement over the original patent, enabling real-time, non-invasive monitoring of cardiovascular health.

Alternative Embodiments and Variations

Alternative embodiments of the inventive concept include implantable sensors, miniaturized sensors, and wearable devices with varying form factors and materials. Variations of the system could include different wavelengths, pulse durations, and beam shapes to optimize performance for specific applications.

Potential Commercial Applications and Market

The next-generation flow monitoring system has significant commercial potential in the healthcare industry, particularly in cardiovascular disease diagnosis and monitoring. The system could be marketed as a wearable device for personal health monitoring, an implantable sensor for continuous monitoring, or a medical imaging device for clinical use.

Field of Art

Biomedical optical sensing and non-invasive flow monitoring technologies, with expertise in optical interference techniques, biomedical imaging, and sensor design for physiological monitoring

Person of Ordinary Skill (PHOSITA) Profile

A biomedical engineer or optical sensing specialist with advanced degree, knowledge of laser-based medical diagnostics, signal processing algorithms, and experience in developing non-invasive monitoring technologies

Obviousness Rationale

A PHOSITA would recognize that extending the source patent's coherent light-based flow monitoring to multi-spectral illumination, spatially-resolved sensing, and three-dimensional imaging represents predictable technological progression using known optical interference techniques. The fundamental principles of light interaction with biological tissues remain consistent, with the PTD introducing incremental improvements in sensor array configuration and signal processing. These variations would be considered routine optimization within the field of non-invasive medical sensing technologies.

Obvious Combinations & Variations

Source Patent Element
Coherent light beam illumination of subsurface vasculature using specific wavelength range (400-1000 nanometers)
PTD Variation
Multi-spectral illumination with expanded wavelength ranges and adaptive beam configurations
Obviousness Reasoning
Selecting multiple wavelengths is a standard technique for improving optical penetration and contrast in biological tissue imaging, representing a predictable design variation known to those skilled in optical sensing
Source Patent Element
External body surface mounting of light source and sensor
PTD Variation
Flexible, conformable substrate with integrated sensors, wireless communication, and thin-film battery
Obviousness Reasoning
Miniaturization and integration of sensing technologies are well-established design approaches in wearable medical devices, representing an obvious technological progression
Source Patent Element
Single light sensor detecting interference patterns
PTD Variation
Array of light sensors providing spatially-resolved, three-dimensional flow pattern imaging
Obviousness Reasoning
Expanding single-point sensing to multi-point sensing arrays is a standard engineering approach for improving measurement resolution and diagnostic capabilities
Source Patent Element
Non-invasive blood flow monitoring at specific body locations
PTD Variation
Implantable and miniaturized sensors for localized and comprehensive flow monitoring
Obviousness Reasoning
Transitioning between external and internal sensing modalities represents a predictable technological evolution driven by clinical requirements and sensor miniaturization capabilities
35 U.S.C. § 103 Summary: Pursuant to 35 U.S.C. ยง 103, the variations disclosed in this Published Technical Disclosure would have been obvious to a Person Having Ordinary Skill In The Art at the time of invention, when considered in light of US Patent 11857301. The incremental technological improvements represent routine optimization of known non-invasive flow monitoring techniques, utilizing predictable combinations of existing optical sensing principles and standard biomedical engineering design approaches.

Original Patent Information

Patent NumberUS 11,857,301
TitleNon-invasive flow monitoring
Assignee(s)VERILY LIFE SCIENCES LLC